FindTrial
Sign In

A study to assess the effect of patient related factors on warfarin dosing.

AN OBSERVATIONAL STUDY TO ASSESS THE EFFECT OF PATIENT SPECIFIC FACTORS ON MAINTAINANCE DOSE OF WARFARIN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/12/006455
Enrollment
100
Registered
2015-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- cardiovascular disease patients recieving warfarin therapy

Interventions

None listed

Sponsors

Ramakanth GSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex in age group between 18 to 65 years on warfarin therapy with INR between 2 to 3.5 and with stable total warfarin maintenance dose for three consecutive months will be included for the study.

Exclusion criteria

Exclusion criteria: Patients with INR outside the range of 2 to 3.5 and non-compliant to warfarin therapy and study procedure will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Evaluation of oneâ??week vitamin K intake on total weekly warfarin doseTimepoint: 1 week—

Secondary

MeasureTime frame
Evaluation of data collected on age, gender and tobacco &/or alcohol consumption on total weekly warfarin doseTimepoint: 1 week—

Countries

India

Contacts

Public ContactRamakanth GSH

Nizams Institute of Medical Sciences

grk234@yahoo.co.in9703633788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026